170P Sintilimab plus anlotinib as first-line therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC)
2015 ◽
Vol 16
(7)
◽
pp. 859-870
◽
Keyword(s):
2016 ◽
Vol 23
(10)
◽
pp. 2405-2413
◽
Keyword(s):
Keyword(s):
Keyword(s):